Arena Pharmaceuticals Inc (NASDAQ:ARNA)

49.47
Delayed Data
As of Jun 15
 -0.16 / -0.32%
Today’s Change
12.20
Today|||52-Week Range
49.85
+45.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues37.0M38.3M124.0M21.3M
 
 
 
 
 
Cost of Goods Sold3.2M3.1M6.0M--
 
 
 
 
Depreciation And Amortization9.2M10.0M9.4M4.3M
 
 
 
 
 
 
Operating ExpensesGross Income24.6M25.2M108.6M--
 
 
 
 
General Expenses129.9M124.4M97.7M97.1M
 
 
 
 
 
Research And Development100.3M88.4M66.4M71.0M
 
 
 
 
 
Total Operating Expenses142.2M137.6M113.0M101.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-105.3M-99.2M11.0M-80.0M
 
 
 
 
 
Extraordinary Credit4.4M474.0K0.00--
 
 
 
Extraordinary Charge0.00-4.0M-28.1M-12.0M
 
 
 
 
Interest Expense On Debt6.9M6.8M6.5M6.1M
 
 
 
 
 
Other Expenses47.2M1.4M472.0K1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-60.5M-108.0M-22.9M-95.9M
 
 
 
 
 
Minority Interest0.000.00-380.0K-1.3M
 
 
 
Discontinued Operations0.000.000.003.1M
 
 
Net Income-60.5M-108.0M-22.5M-91.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS22.0M24.1M24.3M33.0M
 
 
 
 
 
Shares To Calculate EPS Diluted22.0M24.1M24.3M33.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.80-$4.50-$0.90-$2.77
 
 
 
 
 
EPS Diluted-$2.80-$4.50-$0.90-$2.77